Physician profile
Eric Rodgers
NPI 1780773234
$2,019.13
in general payments reported to CMS, 2019-2025
10 companies · $679 in 2025
The $679 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $120 · 2021: $198 · 2022: $255 · 2023: $345 · 2024: $285 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.69 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $973.36 | 2020-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $253.73 | 2023-2025 | Infuse Multifocal, Infuse, Miebo |
| Coopervision INC. | $211.31 | 2019-2023 | Myday Contact Lens |
| Notal Vision, INC. | $140.17 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $134.01 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $131.80 | 2019-2021 | |
| Oyster Point Pharma, INC. | $55.88 | 2022-2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $54.77 | 2020-2022 | |
| Tearlab Corp | $42.65 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $21.45 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.